Newtyn Management’s Epizyme, Inc EPZM Stock Holding History

Newtyn Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,569,995	Closed	-$11.1M	–	94
2022 Q2	$11.1M	Buy	+7,569,995	New	+$5.56M	2.11%	16

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Newtyn Management's EPZM Position: Q3 2022 in Review

Newtyn Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 7,569,995 shares — an estimated $11.1M sold.

Newtyn Management first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $11.1M in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Newtyn Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Newtyn Management sold 7,569,995 Epizyme, Inc shares in Q3 2022, an estimated $11.1M.
Newtyn Management first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Newtyn Management's Epizyme, Inc position peaked at $11.1M in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Newtyn Management's 13F filing for Q3 2022, filed 14 Nov 2022.